Raymond James Financial »

SPDR S&P Pharmaceuticals shares owned by Raymond James Financial

Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in SPDR S&P Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Pharmaceuticals held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Pharmaceuticals by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $783k 16k 47.94
2025-06-30 $525k 13k 40.58
2025-03-31 $979k 22k 43.80
2024-12-31 $762k 18k 42.99

More positions owned by Raymond James Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Wal-Mart Stores (WMT)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Raymond James Financial

Top funds holding SPDR S&P Pharmaceuticals

Morgan Stanley
Envestnet Asset Management
LPL Financial
First Citizens Bank & Trust
Envestnet Portfolio Solutions
Goldman Sachs Group
Susquehanna International
Wells Fargo & Company
Cetera Investment Advisers
Jpmorgan Chase & Co
CX Institutional
Wharton Business Group
Clark Capital Management Group
Bp Wealth Management
Bnp Paribas Arbitrage, Snc

View all funds holding SPDR S&P Pharmaceuticals